Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
27.81
+0.11 (+0.40%)
Official Closing Price
Updated: 7:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
32
33
Next >
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028
May 26, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END
Via
FinancialNewsMedia
Pfizer Presents Scientific Advancements from its Leading Oncology Portfolio at ASCO 2023 Annual Meeting
May 25, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Tuesday Trading
May 23, 2023
Via
Investor Brand Network
Exposures
COVID-19
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Monday Trading
May 22, 2023
Via
Investor Brand Network
Exposures
COVID-19
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Tuesday Trading
May 02, 2023
Via
Investor Brand Network
Exposures
COVID-19
Pfizer’s PAXLOVID™ Receives FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19
May 25, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Has the Prescription for Higher Share Prices
May 25, 2023
Pfizer's 4% yield is more attractive than ever after positive results from a study and an upgrade from Cantor Fitzgerald.
Via
MarketBeat
Topics
Derivatives
Intellectual Property
Exposures
Derivatives
Intellectual Property
Doximity is an Overlooked Medical Ecosystem AI Play
May 23, 2023
Doximity Inc. (NASDAQ: DOCS) is a digital professional social network platform for medical practitioners. It’s a medical community networking platform like
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Lifestyle Drugs Market to Eyewitness Massive Growth : Eli Lilly, Pfizer, BMS, AstraZeneca
May 22, 2023
Stay up-to-date with Lifestyle Drugs Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
Product Safety
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
May 19, 2023
Despite worries about FTC scrutiny, Pfizer remains optimistic about its planned Seagen acquisition, issuing $31 billion in bonds to finance the deal.
Via
MarketBeat
Topics
Bonds
Exposures
Debt Markets
FDA Advisory Committee Votes in Support of Approval for Pfizer’s Vaccine Candidate to Help Prevent RSV in Infants Through Maternal Immunization
May 18, 2023
From
Pfizer Inc.
Via
Business Wire
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
May 18, 2023
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.
Via
MarketBeat
Exposures
Product Safety
Pfizer Prices $31,000,000,000 Debt Offering
May 16, 2023
From
Pfizer Inc.
Via
Business Wire
The Turnaround for Weight Watchers is Taking Shape
May 16, 2023
Weight management meals and services provider WW International Inc. (NYSE: WW) stock made a 52-week high of $10.02 after its Q1 2023 earnings release. Shares
Via
MarketBeat
Oral Cancer Treatment Market Projected to Show Strong Growth : Bristol-Myers Squibb, Qilu Pharmaceutical, Novartis
May 15, 2023
Get Oral Cancer Treatment Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.
Via
SBWire
Is Novavax Finally Turning Things Around?
May 15, 2023
Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious disea
Via
MarketBeat
Exposures
COVID-19
Pfizer Announces Proposed Notes Offering
May 15, 2023
From
Pfizer Inc.
Via
Business Wire
AI for Pharma and Biotech Market Giants Spending Is Going to Boom : PFIZER, Abbott, SANOFI, Atomwise
May 09, 2023
Stay up-to-date with AI for Pharma and Biotech Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results
May 08, 2023
Commercial-state biotechnology company ImmunoGen Inc. (NASDAQ: IMGN) shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug
Via
MarketBeat
Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
May 08, 2023
From
Arvinas Inc.
Via
GlobeNewswire
High-Yield Pfizer Falls Off The COVID Cliff, And Survives
May 02, 2023
Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust.
Via
MarketBeat
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Pfizer Reports First-Quarter 2023 Results
May 02, 2023
From
Pfizer Inc.
Via
Business Wire
U.S. FDA Approves PREVNAR 20®, Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
April 27, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Declares Second-Quarter 2023 Dividend
April 26, 2023
From
Pfizer Inc.
Via
Business Wire
Discover the Best Stocks to Invest In During a Recession
April 26, 2023
In times of economic uncertainty, such as during a recession, it can be challenging to know where to invest your
Via
Spotlight Growth
Topics
Economy
Exposures
Economy
Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal
April 25, 2023
Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgia
Via
MarketBeat
Exposures
Product Safety
6 Best Healthcare Stocks to Buy Right Now
April 25, 2023
Whether you invest in healthcare stocks for pharmaceuticals, medical devices or health insurance, the opportunities are limitless. Learn more with MarketBeat.
Via
MarketBeat
Topics
Economy
Intellectual Property
Exposures
Economy
Intellectual Property
Product Safety
AM Best Affirms Credit Ratings of Blue Whale Re Ltd.
April 21, 2023
From
AM Best
Via
Business Wire
Team MotionGility is All Set to Revolutionize the Internet Marketing Space After Its Grand Success in Animation
April 20, 2023
Via
Get News
Gamida Cell Stock Jumps Over 100% on FDA Approval
April 18, 2023
Gamida Cell Ltd. (NASDAQ: GMDA) is an Israeli-based developmental biotechnology company specializing in discovering and advancing cell therapies to fight bloo
Via
MarketBeat
Exposures
Product Safety
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.